Endoscopic submucosal dissection can be performed as safely and effectively as alternative techniques and is associated with lower cancer recurrence, according to a recent study.
Northwestern Medicine investigators discovered that nuclear surface proteins called nuclear lamin isoforms regulate nuclear pore complexes, shedding light on the role molecular mechanisms play in genetic mutations behind many rare diseases.
A team of Northwestern Medicine scientists have discovered that a specific type of immune cell is necessary for the suppression of chronic inflammation, revealing a potential therapeutic target for patients with rheumatoid arthritis.
Perioperative chemotherapy treatment did not improve overall survival for patients with resectable pancreatic cancer, according to a recent Northwestern Medicine clinical trial.
Working with large, multicenter teams, Northwestern clinician-scientists have examined treatments for blood clotting in critically ill patients with COVID-19, and explored therapies that could reduce disease progression and hospitalization.
Northwestern Medicine investigators have discovered a potential multi-faceted therapeutic target for preventing and treating the metabolic syndrome, according to a recent study.
A new class of drugs shows benefit for both cardiovascular and kidney conditions, but scientists should be cautious in designing trials that include both cardiovascular and kidney outcomes in the same analysis, according to a Northwestern Medicine review article.
Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.
Susan Quaggin, MD, has been elected president of the American Society of Nephrology.
The third annual Northwestern Women in Medicine conference kicked off on December 17, and will feature monthly virtual lectures aimed to empower women in medicine to thrive in a virtual world.